Brief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
24/08/2026 07:17
BRIEF-Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln Aug 24 (Reuters) - Valerio Therapeutics SA ALVIO.PA:
VALERIO THERAPEUTICS ANNOUNCES SIGNING OF DEFINITIVE AGREEMENTS FOR THE ACQUISITION OF ETHERNA IMMUNOTHERAPIES, BUILDING A LEADING PLATFORM IN TARGETED RNA, AND €40.25 MILLION PIPE FINANCING FROM NEW AND EXISTING INVESTORS
VALERIO THERAPEUTICS - TO BUY 100% OF ETHERNA IMMUNOTHERAPIES FOR €30 MILLION ENTERPRISE VALUE
Source text: ID:nBw3C7FPna
Further company coverage: ALVIO.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln